Formosa Pharmaceuticals, Inc. (TPE:6838)
Taiwan · Delayed Price · Currency is TWD 24.90
+0.15 (0.61%)
At close: May 29, 2026
Formosa Pharmaceuticals Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -58.08 | -83.57 | -201.01 | -321.96 | -406.27 | -400.88 |
Depreciation & Amortization | 50.54 | 48.42 | 41.87 | 40.3 | 39.15 | 37.63 |
Other Amortization | 1.14 | 1.14 | 0.41 | 0.24 | 0.25 | 0.1 |
Loss (Gain) From Sale of Assets | - | - | - | - | - | 0.2 |
Stock-Based Compensation | 0.21 | 0.36 | 36.2 | 2.42 | 2.59 | - |
Provision & Write-off of Bad Debts | - | - | 7.82 | - | - | - |
Other Operating Activities | -0 | -3.54 | 25.08 | 55.09 | -0.39 | 38.79 |
Change in Accounts Receivable | -26.2 | - | -7.82 | - | -0.03 | - |
Change in Inventory | -2.85 | -1.28 | -2.89 | - | - | - |
Change in Accounts Payable | 2.61 | 0.77 | - | 24.52 | 26.29 | 6.11 |
Change in Unearned Revenue | -3.55 | 10.07 | -77.01 | 41.1 | - | - |
Change in Other Net Operating Assets | -46.47 | -68.01 | 48.67 | -37.75 | -7.73 | -13.07 |
Operating Cash Flow | -82.65 | -95.64 | -128.68 | -196.04 | -346.15 | -331.13 |
Capital Expenditures | -1.34 | -10.01 | -7.27 | -2.17 | - | -0.22 |
Cash Acquisitions | - | - | -79.29 | - | -29.87 | -71.03 |
Sale (Purchase) of Intangibles | -31.88 | -31.88 | -0.98 | -0.08 | - | -14.85 |
Investment in Securities | 220 | 20 | -387.27 | -673.98 | -158.75 | - |
Other Investing Activities | -47.45 | -46.4 | -0.49 | 0.02 | -0.02 | - |
Investing Cash Flow | 139.32 | -68.29 | -475.29 | -676.21 | -188.64 | -86.1 |
Long-Term Debt Repaid | - | -6.13 | -6.05 | -4.62 | -3.07 | -3.03 |
Net Debt Issued (Repaid) | -6.39 | -6.13 | -6.05 | -4.62 | -3.07 | -3.03 |
Issuance of Common Stock | - | - | 630.45 | 1,005 | 503.54 | 608 |
Other Financing Activities | - | - | - | - | 58.39 | - |
Financing Cash Flow | -6.39 | -6.13 | 624.4 | 999.88 | 558.86 | 604.97 |
Foreign Exchange Rate Adjustments | -41.83 | -13.94 | 20.65 | -10.26 | 34.35 | -20.68 |
Net Cash Flow | 8.44 | -184 | 41.08 | 117.37 | 58.42 | 167.05 |
Free Cash Flow | -84 | -105.65 | -135.95 | -198.21 | -346.15 | -331.35 |
Free Cash Flow Margin | -154.63% | -1112.70% | -94.83% | -635.85% | -26323.19% | -1161.46% |
Free Cash Flow Per Share | -0.56 | -0.70 | -0.96 | -1.60 | -3.29 | -3.58 |
Cash Interest Paid | 0.5 | 0.49 | 0.57 | 0.76 | 0.99 | 0.08 |
Cash Income Tax Paid | 0.44 | 0.06 | 0.88 | 3.13 | 0.07 | 2.89 |
Levered Free Cash Flow | -162.32 | -123.66 | -109.71 | 9.74 | -156.49 | -255.47 |
Unlevered Free Cash Flow | -162 | -123.36 | -109.35 | 12.43 | -155.87 | -254.09 |
Change in Working Capital | -76.46 | -58.45 | -39.05 | 27.87 | 18.53 | -6.96 |